Gastrointestinal endoscopy in patients taking antiplatelet agents and anticoagulants: Survey of ASGE members

被引:43
|
作者
Kadakia, SC
Angueira, CE
Ward, JA
Moore, M
机构
[1] BROOKE ARMY MED CTR,DEPT MED,SAN ANTONIO,TX 78234
[2] BROOKE ARMY MED CTR,DEPT CLIN INVEST,SAN ANTONIO,TX 78234
关键词
D O I
10.1016/S0016-5107(96)70170-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Gastrointestinal endoscopy is often required in patients taking aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), or anticoagulants. Because proper guidelines are lacking, we believe that most endoscopists use their own criteria and judgment for stopping and restarting these agents during the periendoscopic period, and the practice varies widely. The aim of our study was to identify these practices among ASGE members. Methods: Questionnaires, each containing 22 questions with 157 responses, were sent to 3300 ASGE members, including all Gastroenterology Fellowship Program Directors. One thousand two hundred sixty-nine questionnaires were received and analyzed. Results: Physicians stopped aspirin and NSAIDs more frequently before colonoscopy (81%) and ERCP (79%) than before upper endoscopy (51%) (p < 0.001). Ninety percent of physicians stopped aspirin and NSAIDs for 10 or fewer days. Only 20% of physicians performed sphincterotomy when aspirin and NSAIDs were not stopped compared with 88% and 85% (p < 0.001 for both) of physicians performing cold biopsies at esophagogastroduodenoscopy and colonoscopy, respectively, and 77% and 69% performing hot biopsies for the same procedures (p < 0.001 for all compared with sphincterotomy). Depending on the indication for anticoagulation, 51% to 60% of physicians stopped warfarin before upper endoscopy; 71% to 82% before colonoscopy; and 26% to 51% of physicians used a ''heparin window.'' All physicians restarted warfarin immediately after diagnostic endoscopy, whereas 80% restarted it 7 or fewer days after therapeutic endoscopy. Conclusions: We conclude that a wide variation exists regarding the management of aspirin, NSAIDs, and anticoagulants in the periendoscopic period. There is a definite need for a consensus statement or guidelines for managing patients taking these agents.
引用
收藏
页码:309 / 316
页数:8
相关论文
共 50 条
  • [21] Uptake of guidelines in the management of patients taking anticoagulants and antiplatelet agents presenting for elective surgery
    Cheung, K.
    Halliwell, R.
    Cope, L.
    Khong, D.
    ANAESTHESIA AND INTENSIVE CARE, 2012, 40 (06) : 1046 - 1052
  • [22] Management of anticoagulants and antiplatelet agents in elective endoscopy: Weighing the risks and benefits
    Belletrutti, Paul J.
    Heitman, Steven J.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 21 (09) : 553 - 555
  • [23] No Benefit From Platelet Transfusion for Gastrointestinal Bleeding in Patients Taking Antiplatelet Agents
    Zakko, Liam
    Rustagi, Tarun
    Douglas, Maura
    Laine, Loren
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (01) : 46 - 52
  • [24] Endoscopy and antiplatelet agents. European Society of Gastrointestinal Endoscopy (ESGE) Guideline
    Boustiere, C.
    Veitch, A.
    Vanbiervliet, G.
    Bulois, P.
    Deprez, P.
    Laquiere, A.
    Laugier, R.
    Lesur, G.
    Mosler, P.
    Nalet, B.
    Napoleon, B.
    Rembacken, B.
    Ajzenberg, N.
    Collet, J. P.
    Baron, T.
    Dumonceau, J. -M.
    ENDOSCOPY, 2011, 43 (05) : 445 - 458
  • [25] Rattlesnake Envenomations in Patients on Anticoagulants and Antiplatelet Agents
    Levine, M.
    Ruha, A-M
    French, R.
    CLINICAL TOXICOLOGY, 2010, 48 (06) : 627 - 627
  • [26] Dentistry concerns for patients taking anticoagulants and antiplatelet drugs
    Sambrook, Paul
    AUSTRALIAN PRESCRIBER, 2018, 41 (04) : 116 - 116
  • [27] Endoscopy in patients taking aspirin and warfarin: A survey of British Society of Gastroenterology members
    Heaney, A
    Tham, TCK
    GUT, 2001, 48 : A92 - A92
  • [28] Endoscopic biopsy on patients taking antiplatelet agents: How much do we follow BSG, ASGE or ESGE guidelines?
    Misro, Aswini
    Sheth, Hemant
    Pal, Arabinda
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2014, 33 (02) : 195 - 196
  • [29] Endoscopic biopsy on patients taking antiplatelet agents: How much do we follow BSG, ASGE or ESGE guidelines?
    Aswini K. Misro
    Hemant Sheth
    Arabinda Pal
    Indian Journal of Gastroenterology, 2014, 33 (2) : 195 - 196
  • [30] Review: the safety of anticoagulants and antiplatelet agents in patients with cirrhosis
    Ma, Jiayi
    Chalasani, Naga P.
    Schwantes-An, Linus
    Bjornsson, Einar Stefan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (01) : 52 - 71